Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Neuhaus

Showing results (671-680 of 830) with videos related to

Pageof 83
Sort By:
Transplantation Proceedings|April 6, 2005
Significant reduction of proinflammatory cytokines by treatment of the brain-dead donorO Kuecuek, L Mantouvalou, R Klemz, et al.
Journal of Hepatology|November 1, 1991
Follow-up of recurrent hepatitis B and delta infection in liver allograft recipients after treatment with recombinant interferon-alphaU Hopf, P Neuhaus, H Lobeck, et al.
Transplantation Proceedings|September 25, 2002
Improvement of left ventricular function and arterial blood pressure 1 year after simultaneous pancreas kidney transplantationM Oppert, U Schneider, W Bocksch, et al.
Hepatology (Baltimore, Md.)|November 1, 1992
Hepatitis C virus reinfection in allografts after orthotopic liver transplantationV König, J Bauditz, H Lobeck, et al.
Clinical Transplantation|June 1, 1995
The optimal immunosuppressant after liver transplantation according to diagnosis: cyclosporine A or FK506?A R Mueller, K P Platz, G Blumhardt, et al.
Transplantation Proceedings|February 1, 1995
The superior immunosuppressant according to diagnosis: FK 506 or cyclosporine AA R Mueller, K P Platz, G Blumhardt, et al.
Transplantation Proceedings|August 1, 1993
Influence of SOD, catalase, and epoprostenol on 24-hour liver preservation in pigsH P Lemmens, M R Schön, G Blumhardt, et al.
Transplantation|April 27, 1995
Comparison of polymerase chain reaction from plasma and buffy coat with antigen detection and occurrence of immunoglobulin M for the demonstration of cytomegalovirus infection after liver transplantationC A Schmidt, H Oettle, R Peng, et al.
Transplantation Proceedings|December 1, 1996
BT563 significantly decreases sIL-2R plasma levels despite acute allograft rejectionA R Mueller, K P Platz, T Steinmüller, et al.
Transplantation Proceedings|June 24, 1998
Risk and benefit of antibody induction therapy in combination with tacrolimus immunosuppression after liver transplantationJ Klupp, W O Bechstein, J Pratschke, et al.
Pageof 83

Showing results (671-680 of 830) with videos related to

Sort By:
Pageof 83
Transplantation Proceedings|April 6, 2005
Significant reduction of proinflammatory cytokines by treatment of the brain-dead donorO Kuecuek, L Mantouvalou, R Klemz, et al.
Journal of Hepatology|November 1, 1991
Follow-up of recurrent hepatitis B and delta infection in liver allograft recipients after treatment with recombinant interferon-alphaU Hopf, P Neuhaus, H Lobeck, et al.
Transplantation Proceedings|September 25, 2002
Improvement of left ventricular function and arterial blood pressure 1 year after simultaneous pancreas kidney transplantationM Oppert, U Schneider, W Bocksch, et al.
Hepatology (Baltimore, Md.)|November 1, 1992
Hepatitis C virus reinfection in allografts after orthotopic liver transplantationV König, J Bauditz, H Lobeck, et al.
Clinical Transplantation|June 1, 1995
The optimal immunosuppressant after liver transplantation according to diagnosis: cyclosporine A or FK506?A R Mueller, K P Platz, G Blumhardt, et al.
Transplantation Proceedings|February 1, 1995
The superior immunosuppressant according to diagnosis: FK 506 or cyclosporine AA R Mueller, K P Platz, G Blumhardt, et al.
Transplantation Proceedings|August 1, 1993
Influence of SOD, catalase, and epoprostenol on 24-hour liver preservation in pigsH P Lemmens, M R Schön, G Blumhardt, et al.
Transplantation|April 27, 1995
Comparison of polymerase chain reaction from plasma and buffy coat with antigen detection and occurrence of immunoglobulin M for the demonstration of cytomegalovirus infection after liver transplantationC A Schmidt, H Oettle, R Peng, et al.
Transplantation Proceedings|December 1, 1996
BT563 significantly decreases sIL-2R plasma levels despite acute allograft rejectionA R Mueller, K P Platz, T Steinmüller, et al.
Transplantation Proceedings|June 24, 1998
Risk and benefit of antibody induction therapy in combination with tacrolimus immunosuppression after liver transplantationJ Klupp, W O Bechstein, J Pratschke, et al.
Pageof 83